PRO-2844

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePRO-2844
Drug Alias NamePRO-2844
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsPsoriasisDermatitisSkin Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPaligent Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPaligent Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisDermatitisSkin Diseases

Other Information

ATC CodeN/A
Related LinksN/A